Lansoprazole pharmacokinetics differ in patients with oesophagitis compared to healthy volunteers

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 9, 1999, Pages 1215-1219

  Barclay, M L ^a   Begg, E J ^a   Robson, R A ^a   Peters, W A ^b   Ketelbey, J W ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b Lederle Laboratories   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STEADY STATE; WELLBEING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; ESOPHAGITIS, PEPTIC; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; REFERENCE VALUES;

EID: 0032877692     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00595.x     Document Type: Article

References (5)

1. Delhotal Landes B, Petite JP, Flouvat B. Clinical pharmacokinetics of lansoprazole. Clin Pharmacokinet 1996; 28: 458-70.
2. Flouvat B, Delhotal Landes B, Cournot A, Dellatolas F. Single and multiple dose pharmacokinetics of lansoprazole in elderly subjects. Br J Clin Pharmacol 1993; 36: 467-9.
3. Hussein Z, Granneman GR, Mukherjee D, et al. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. Br J Clin Pharmacol 1993; 36: 391-8.
4. Yamada A, Ubara Y, Katori H, et al. Effect and pharmacokinetics of lansoprazole in patients with peptic ulcer and reflux oesnphagitis with severe renal failure. Ther Res 1996; 17: 347-51.
5. Delhotal Landes B, Flouvat B, Duchier J, et al. Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity. Eur J Clin Pharmacol 1993; 45: 367-71.